Despite strong performance, AVITA Medical's P/S ratio remain...
Despite strong performance, AVITA Medical's P/S ratio remains low, as investors fear possible revenue growth deceleration. The company's growth projection lags behind the industry's, potentially contributing to its low P/S ratio. Without significant revenue improvements, the stock price may stall.
Why Investors Shouldn't Be Surprised By AVITA Medical, Inc.'s (NASDAQ:RCEL) 32% Share Price Plunge
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment